A peptide-based NF-κB siRNA NP which prevents the expression of the NF-κB signaling pathway could be rapidly delivered to ATLL, thereby inhibiting ATLL growth and sensitizing advanced ATLL to etoposide [160]. The gene discussed is NFKB1; the disease is adult T-cell leukemia/lymphoma.